These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31400757)

  • 41. Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells.
    Ko PH; Lenka G; Chen YA; Chuang EY; Tsai MH; Sher YP; Lai LC
    Int J Oncol; 2020 Jan; 56(1):165-177. PubMed ID: 31789397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. (-)-β-hydrastine suppresses the proliferation and invasion of human lung adenocarcinoma cells by inhibiting PAK4 kinase activity.
    Guo B; Li X; Song S; Chen M; Cheng M; Zhao D; Li F
    Oncol Rep; 2016 Apr; 35(4):2246-56. PubMed ID: 26821251
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fructus phyllanthi tannin fraction induces apoptosis and inhibits migration and invasion of human lung squamous carcinoma cells in vitro via MAPK/MMP pathways.
    Zhao HJ; Liu T; Mao X; Han SX; Liang RX; Hui LQ; Cao CY; You Y; Zhang LZ
    Acta Pharmacol Sin; 2015 Jun; 36(6):758-68. PubMed ID: 25864648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling.
    Geng F; Jiang Z; Song X; Zhou H; Zhao H
    Int J Oncol; 2017 Dec; 51(6):1898-1908. PubMed ID: 29039479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway.
    Zhang Y; Zhang Q; Chen H; Wang C
    Life Sci; 2018 Sep; 208():284-294. PubMed ID: 30009824
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Doxycycline reverses epithelial-to-mesenchymal transition and suppresses the proliferation and metastasis of lung cancer cells.
    Qin Y; Zhang Q; Lee S; Zhong WL; Liu YR; Liu HJ; Zhao D; Chen S; Xiao T; Meng J; Jing XS; Wang J; Sun B; Dai TT; Yang C; Sun T; Zhou HG
    Oncotarget; 2015 Dec; 6(38):40667-79. PubMed ID: 26512779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Shikonin Inhibited Migration and Invasion of Human Lung Cancer Cells via Suppression of c-Met-Mediated Epithelial-to-Mesenchymal Transition.
    Hsieh YS; Liao CH; Chen WS; Pai JT; Weng MS
    J Cell Biochem; 2017 Dec; 118(12):4639-4651. PubMed ID: 28485480
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA-197 induces epithelial-mesenchymal transition and invasion through the downregulation of HIPK2 in lung adenocarcinoma.
    Zhang N; Tian L; Miao Z; Guo N
    J Genet; 2018 Mar; 47(1):47-53. PubMed ID: 29666324
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis.
    Yang HL; Thiyagarajan V; Shen PC; Mathew DC; Lin KY; Liao JW; Hseu YC
    J Exp Clin Cancer Res; 2019 May; 38(1):186. PubMed ID: 31068208
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduced CENPU expression inhibits lung adenocarcinoma cell proliferation and migration through PI3K/AKT signaling.
    Li J; Wang ZG; Pang LB; Zhang RH; Wang YY
    Biosci Biotechnol Biochem; 2019 Jun; 83(6):1077-1084. PubMed ID: 30849291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
    Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
    Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FAM83A-AS1 promotes lung adenocarcinoma cell migration and invasion by targeting miR-150-5p and modifying MMP14.
    Xiao G; Wang P; Zheng X; Liu D; Sun X
    Cell Cycle; 2019 Nov; 18(21):2972-2985. PubMed ID: 31522616
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibitory effect of quercetin on colorectal lung metastasis through inducing apoptosis, and suppression of metastatic ability.
    Kee JY; Han YH; Kim DS; Mun JG; Park J; Jeong MY; Um JY; Hong SH
    Phytomedicine; 2016 Dec; 23(13):1680-1690. PubMed ID: 27823633
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A polysaccharide from Hedyotis diffusa interrupts metastatic potential of lung adenocarcinoma A549 cells by inhibiting EMT via EGFR/Akt/ERK signaling pathways.
    Lin L; Cheng K; He Z; Lin Q; Huang Y; Chen C; Xie Z; Chen L; Liang Z
    Int J Biol Macromol; 2019 May; 129():706-714. PubMed ID: 30738900
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells.
    An J; Xue Y; Long M; Zhang G; Zhang J; Su H
    Oncotarget; 2017 Jun; 8(24):39230-39240. PubMed ID: 28424406
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ethanol extracts of fruiting bodies of Antrodia cinnamomea exhibit anti-migration action in human adenocarcinoma CL1-0 cells through the MAPK and PI3K/AKT signaling pathways.
    Chen YY; Chou PY; Chien YC; Wu CH; Wu TS; Sheu MJ
    Phytomedicine; 2012 Jun; 19(8-9):768-78. PubMed ID: 22464013
    [TBL] [Abstract][Full Text] [Related]  

  • 57. YXQ-EQ Induces Apoptosis and Inhibits Signaling Pathways Important for Metastasis in Non-Small Cell Lung Carcinoma Cells.
    Yan X; Shen H; Jiang H; Hu D; Wang J; Wu X
    Cell Physiol Biochem; 2018; 49(3):911-919. PubMed ID: 30184531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial-Mesenchymal Transition.
    Pang B; Wu N; Guan R; Pang L; Li X; Li S; Tang L; Guo Y; Chen J; Sun D; Sun H; Dai J; Bai J; Ji G; Liu P; Liu A; Wang Q; Xiao S; Fu S; Jin Y
    Clin Cancer Res; 2017 Sep; 23(18):5598-5610. PubMed ID: 28606921
    [No Abstract]   [Full Text] [Related]  

  • 60. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
    Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
    Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.